SMO ClinPlus CO.,LTD.

Equities

301257

CNE100005CP8

Healthcare Facilities & Services

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 20/06/2024 BST			5-day change	1st Jan Change
29.75 ^CNY	+1.40%		-2.40%	-39.09%

05-30	Smo Clinplus Co.,Ltd. Announces Final Profit Distribution for 2023, Payable on 06 June 2024	CI
05-17	Certain A-Shares of SMO ClinPlus CO.,LTD. are subject to a Lock-Up Agreement Ending on 17-MAY-2024.	CI

Smo Clinplus Co.,Ltd. Announces Final Profit Distribution for 2023, Payable on 06 June 2024

May 30, 2024 at 08:32 pm

SMO ClinPlus CO.,LTD. announced 2023 final profit distribution plan to be implemented (A shares): Cash dividend/10 shares (tax included): CNY 1.66010000. Record date is 05 June 2024. Ex-date: 06 June 2024.

Payment date: 06 June 2024.

Latest news about SMO ClinPlus CO.,LTD.

Smo Clinplus Co.,Ltd. Announces Final Profit Distribution for 2023, Payable on 06 June 2024	05-30	CI
Certain A-Shares of SMO ClinPlus CO.,LTD. are subject to a Lock-Up Agreement Ending on 17-MAY-2024.	05-16	CI
SMO ClinPlus CO.,LTD. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-28	CI
SMO ClinPlus CO.,LTD. Reports Earnings Results for the Full Year Ended December 31, 2023	04-28	CI
SMO ClinPlus CO.,LTD. Announces Dividend Implementation for Third Quarter of 2023 for A Shares, Payable on 11 December 2023	12-04	CI
SMO ClinPlus CO.,LTD. Approves Cash Dividend for the Third Quarter of 2023	11-17	CI
Smo Clinplus Co.,Ltd. Proposes Cash Dividend for Third Quarter 2023	30/10/23	CI
SMO ClinPlus CO.,LTD. Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23	CI
SMO ClinPlus CO.,LTD. Reports Earnings Results for the Half Year Ended June 30, 2023	27/08/23	CI
Smo Clinplus Co.,Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on July 6, 2023	29/06/23	CI
SMO ClinPlus CO.,LTD. Approves Cash Dividend for 2022	18/05/23	CI
Certain A-Shares of SMO ClinPlus CO.,LTD. are subject to a Lock-Up Agreement Ending on 17-MAY-2023.	16/05/23	CI
SMO ClinPlus CO.,LTD. Proposes Cash Dividend for 2022	27/04/23	CI
SMO ClinPlus CO.,LTD. Reports Earnings Results for the Full Year Ended December 31, 2022	24/04/23	CI
SMO ClinPlus CO.,LTD. Announces Executive Elections	17/03/23	CI
SMO ClinPlus CO.,LTD. Reports Earnings Results for the Nine Months Ended September 30, 2022	26/10/22	CI
SMO ClinPlus Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	29/08/22	CI
SMO ClinPlus CO.,LTD. has completed an IPO in the amount of CNY 702 million.	09/05/22	CI
SMO ClinPlus CO.,LTD. has filed an IPO.	13/01/22	CI

Chart SMO ClinPlus CO.,LTD.

Duration

Period

More charts

Company Profile

SMO Clinplus Co Ltd is a China-based company principally engaged in the provision of Site Management Organization (SMO) services. The Company mainly provides SMO services for domestic and foreign pharmaceutical companies, medical device companies and clinical research and development of some health-related products. The Company provides customers with services including pre-preparation planning, start-up of test sites, on-site execution and full-process management of projects. The Company operates its businesses both in the domestic market and overseas markets.

Sector

Healthcare Facilities & Services

Calendar

26/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

29.75

Average target price

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

	1st Jan change	Capi.
SMO CLINPLUS CO.,LTD.	-39.09%	326M
SONIC HEALTHCARE LIMITED	-17.27%	8.65B
RADNET, INC.	+68.94%	4.34B
SYNLAB AG	-2.45%	2.69B
DR. LAL PATHLABS LIMITED	+4.34%	2.66B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-55.09%	1.8B
NEOGENOMICS, INC.	-18.60%	1.68B
FLEURY S.A.	-21.18%	1.42B
METROPOLIS HEALTHCARE LIMITED	+15.60%	1.19B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-49.14%	1.03B

Medical & Diagnostic Laboratories